Observational studyBMC pulmonary medicine2026
Diagnostic and prognostic value of the injury-inflammation-fibrosis serum biomarker panel (KL-6, SAA, YKL-40) in lung cancer treatment-associated ILD.
Shuilian Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.